BMO Capital analyst John Kim maintained a Sell rating on National Health Investors (NYSE:NHI) on Friday, setting a price target of $70, which is approximately 4.88% below the present share price of $73.59.
Kim expects National Health Investors to post earnings per share (EPS) of $0.83 for the second quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Hold rating of shares in National Health Investors, with an average price target of $73.75.
The analysts price targets range from a high of $77 to a low of $70.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $81.24 million and a net profit of $54.17 million. The company's market cap is $3.35 billion.
According to TipRanks.com, BMO Capital analyst John Kim is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 2.0% and a 53.66% success rate.
National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.